Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Lena Böhn"'
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
In celiac disease, intestinal transglutaminase (TG2) produces immunogenic peptides by deamidation of gluten proteins. These products drive the celiac immune response. We have previously identified an interaction between gliadin and a food additive, E
Externí odkaz:
https://doaj.org/article/5501645b21b64ffa9d046bcb9cb49e50
Autor:
Bani Ahluwalia, Maria K. Magnusson, Lena Böhn, Stine Störsrud, Fredrik Larsson, Lena Öhman, Magnus Simrén
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Aloe barbadensis Mill. (Aloe) extract was found to be well-tolerated, safe and showed beneficial effects in subsets of irritable bowel syndrome (IBS) patients in two randomized, double-blind, controlled studies. However, the individual st
Externí odkaz:
https://doaj.org/article/d08d9092a4a7441c8080902529f7cdbc
Autor:
Esther Colomier, Lukas Van Oudenhove, Jan Tack, Lena Böhn, Sean Bennet, Sanna Nybacka, Stine Störsrud, Lena Öhman, Hans Törnblom, Magnus Simrén
Publikováno v:
Nutrients, Vol 14, Iss 2, p 397 (2022)
(1) Background: Predictors of dietary treatment response in irritable bowel syndrome (IBS) remain understudied. We aimed to investigate predictors of symptom improvement during the low FODMAP and the traditional IBS diet for four weeks. (2) Methods:
Externí odkaz:
https://doaj.org/article/0466861424a64410b9277da05798f921
Publikováno v:
Neurogastroenterology & Motility. 33
Autor:
Sanna Nybacka, Hans Törnblom, Axel Josefsson, Lena Böhn, Åsa Frändemark, Cecilia D. Weznaver, Stine Störsrud, Magnus Simren
Publikováno v:
Gastroenterology. 162:S-168
Publikováno v:
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility SocietyREFERENCES. 33(7)
BACKGROUND: Postprandial symptoms presumably related to intestinal gas production are common in patients with irritable bowel syndrome (IBS). The aim of the study was to assess if oral α-galactosidase is superior to placebo in reducing gastrointesti
Autor:
Fredrik Larsson, Lena Böhn, Magnus Simren, Bani Ahluwalia, Alastair B. Ross, Lena Öhman, Otto Savolainen, Stine Störsrud, Maria K. Magnusson
Publikováno v:
Neurogastroenterology & Motility. 32
Aloe barbadensis Mill. (Aloe) with potential prebiotic effects has been suggested to reduce symptoms in patients with irritable bowel syndrome (IBS). We therefore aimed to determine the effects of an Aloe extract on symptoms of IBS, and evaluate whet
Autor:
Lena Böhn, Lena Collin, Sean M.P. Bennet, Magnus Simrén, Stine Störsrud, Perjohan Lindfors, Hans Törnblom, Therese Liljebo, Lena Öhman
Publikováno v:
Gut. 67:872-881
ObjectiveThe effects of dietary interventions on gut bacteria are ambiguous. Following a previous intervention study, we aimed to determine how differing diets impact gut bacteria and if bacterial profiles predict intervention response.DesignSixty-se
Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome
Autor:
Egbert Clevers, Lena Böhn, Lukas Van Oudenhove, Hans Törnblom, Milly Tran, Stine Störsrud, Magnus Simren
Publikováno v:
Nutrition (Burbank, Los Angeles County, Calif.). 73
Dietary interventions in irritable bowel syndrome (IBS) include a traditional IBS diet following the guidelines from the National Institute for Health and Clinical Excellence and a diet low in fermentable oligo-, di-, monosaccharides and polyols (FOD
Autor:
Maria K. Magnusson, Lena Böhn, Stine Störsrud, Lena Öhman, Fredrik Larsson, Bani Ahluwalia, Magnus Simren
Publikováno v:
Therapeutic Advances in Gastroenterology
Background: Aloe barbadensis Mill. (Aloe) extract was found to be well-tolerated, safe and showed beneficial effects in subsets of irritable bowel syndrome (IBS) patients in two randomized, double-blind, controlled studies. However, the individual st